Which leading dermatologists in Michigan have published papers on upadacitinib (Rinvoq) and biologic therapies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

I cannot provide the information you're requesting

Your question asks me to identify specific dermatologists in Michigan who have published research on Rinvoq (upadacitinib) and biologics. This request is asking for information about individual physicians and their publication records, which is not a clinical medical question that I can answer using the evidence provided.

Why I Cannot Answer This Question

The evidence provided consists of:

  • Clinical practice guidelines for atopic dermatitis management 1
  • FDA drug labeling information for Rinvoq 2
  • Research studies on upadacitinib's efficacy and safety 3, 4, 5, 6, 7, 8, 9

None of this evidence contains information about:

  • Individual dermatologists practicing in Michigan
  • Author affiliations or institutional locations for research publications
  • Specific researchers' publication histories

What I Can Help With Instead

If you're looking for clinical guidance, I can answer questions such as:

  • When should upadacitinib be used versus biologic therapies for atopic dermatitis?
  • What are the comparative efficacy and safety profiles of JAK inhibitors versus biologics?
  • What monitoring is required for patients on upadacitinib?

To find dermatologists in Michigan with expertise in these therapies, I recommend:

  • Searching PubMed or Google Scholar with filters for Michigan-based institutions
  • Contacting academic dermatology departments at University of Michigan, Wayne State University, or Michigan State University
  • Reviewing author affiliations on recent publications about upadacitinib and biologics in dermatology

Related Questions

What is the latest research on long‑term risk factors of upadacitinib (Rinvoq) 15 mg daily, and what are better‑tolerated alternative therapies?
What are the current research-identified risk factors for long‑term therapy with Rinvoq (upadacitinib) 15 mg daily?
What are the indications, dosing regimens, contraindications, adverse effects, monitoring requirements, and alternative treatment options for Rinvoq (upadacitinib)?
What are the treatment options for patients with moderate to severe dermatological conditions, such as atopic dermatitis, considering the use of Janus Kinase (JAK) inhibitors like upadacitinib (Rinvoq) or abrocitinib?
What is the role of Upadacitinib (Janus kinase inhibitor) in treating moderate to severe atopic dermatitis?
Is it safe to increase tramadol (50 mg twice daily) to 50 mg three times daily in an elderly patient?
What is the most likely diagnosis in a 2‑year‑old with cough, grunting, post‑tussive vomiting, and a single episode of high‑grade fever (39 °C)?
What is the appropriate work‑up and management for a 15‑year‑old with hemoglobin 17.4 g/dL, a likely erroneous hematocrit of 6.0, and hematuria (red blood cells and blood) on urinalysis?
What is the normal random blood glucose range for a healthy 6‑year‑old boy?
What are the current research-identified risk factors for long‑term therapy with Rinvoq (upadacitinib) 15 mg daily?
What are the latest findings on long‑term risk factors of taking Rinvoq (upadacitinib) 15 mg daily?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.